Ravi Bajaj
Interventional Cardiology · Wichita, KSNPI 1013909746
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,266 of the $10,212 with a category attached, or 80.9%. 28 manufacturers reported payments, led by Medtronic at 41.5% of the total. Reporting peaked in 2021 at $3,237 and has fallen 60.6% since, to $1,275 in 2023. That places this record below the midpoint for interventional cardiology clinicians in KS, where the typical reported total is $8,846.
Across 252 payments — averaging $40.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- AstraZeneca$684
- Abiomed$664
- Abbott$638
- Boston Scientific$560
- Pfizer$527
- plus $3K from 22 others
What the payments were for
- Grants$551%
- Travel & lodging$1,83518%
- Food & beverage$8,26681%
- Education$561%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 99 | $4,234 |
| AstraZeneca | 23 | $684 |
| Abiomed | 6 | $664 |
| Abbott | 12 | $638 |
| Boston Scientific | 10 | $560 |
| Pfizer | 26 | $527 |
| E.r. Squibb & Sons, L.L.C. | 18 | $350 |
| Philips North America LLC | 3 | $308 |
| Amgen | 9 | $304 |
| ZOLL Circulation Inc | 3 | $282 |
| Johnson & Johnson | 10 | $232 |
| Coala Life Inc | 2 | $228 |
| Shockwave Medical, Inc | 2 | $208 |
| Edwards Lifesciences | 1 | $180 |
| Impulse Dynamics (USA) Inc. | 1 | $144 |
| Angiodynamics, Inc. | 1 | $120 |
| Merck | 2 | $105 |
| Actelion Pharmaceuticals US, Inc. | 3 | $85 |
| Cvrx, Inc. | 1 | $80 |
| Novartis | 4 | $52 |
| Regeneron Healthcare Solutions, Inc. | 3 | $40 |
| Cardinal Health 200 LLC | 2 | $36 |
| Sanofi-aventis U.S. LLC | 3 | $36 |
| Lundbeck LLC | 2 | $35 |
| Alnylam Pharmaceuticals Inc. | 2 | $29 |
| Boehringer Ingelheim | 2 | $27 |
| Amarin Pharma, Inc. | 1 | $17 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$644
- VenaSeal$558
- Micra$437
- OPTIMIZER$287
- IGT D Coronary$183
- WATCHMAN Access System$141
- Coala Heart Monitor$139
- Confirm Rx$131
- XARELTO$125
- Vascular Lithotripsy$124
- Repatha$124
- FARXIGA$124
- ELIQUIS$120
- Auryon Laser System 100-120 Vac$120
- MitraClip System$111
- Claria MRI$110
- Watchman$108
- CoreValve Evolut$103
How this compares
$10,212 in reported general payments places this provider in the 50th percentile of 55 interventional cardiology providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 103 | $127,485 |
| ClopidogrelClopidogrel Bisulfate | 137 | $943 |
| Metoprolol Tartrate | 174 | $888 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 36 | $784 |
| Carvedilol | 93 | $658 |
| Potassium Chloride | 39 | $582 |
| Metoprolol Succinate | 83 | $529 |
| SotalolSotalol Hcl | 31 | $417 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 23 | $351 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 14 | $280 |
| Amlodipine Besylate | 49 | $232 |
| Lisinopril | 49 | $215 |
| Nitroglycerin | 24 | $209 |
| Amiodarone Hcl | 11 | $175 |
| Furosemide | 43 | $167 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $527 | $127,485103 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 55 interventional cardiology providers in Kansas.
Other interventional cardiology in Wichita
- Maheedhar GedelaWichita$54K
- Hussam FarhoudWichita$25K
- Christian HouraniWichita$17K
- Gaurav TyagiWichita$13K
- Assem FarhatWichita$9K
- Venkata BoppanaWichita$9K
- Alaa BouladWichita$8K
- Rohma ShaikhWichita$4K
- George ReaderWichita$4K
- Mohamed ElmassryWichita$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.